AB042. P013. LncRNA-PTCHD3P1 enhances chemosensitivity of gemcitabine in pancreatic cancer and inhibits cancer cell proliferation and metastasis via inhibiting Warburg effect
Abstract

AB042. P013. LncRNA-PTCHD3P1 enhances chemosensitivity of gemcitabine in pancreatic cancer and inhibits cancer cell proliferation and metastasis via inhibiting Warburg effect

Jiabei Wang1, Keyu Li2

1The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China;2West China Hospital, Chengdu 610041, China


Abstract: Warburg effect is associated with cancer chemosensitivity, and gemcitabine can increase the level of Warburg effect in pancreatic cancer. However, whether lncRNAs has impact on Warburg effect and further affect the chemosensitivity of gemcitabine, the proliferation and metastasis of pancreatic cancer are still unknown. In our previous researches, we have demonstrated that the expression of lncRNA-PTCHD3P1 is decreased in pancreatic cancer, and this reduction significantly inhibits Warburg effect, enhances chemosensitivity of gemcitabine, and inhibits pancreatic cancer cell proliferation and metastasis. In addition, lncRNA-PTCHD3P1 also suppresses the expression of phosphofructokinase-1 (PFK-1), the key factor of glycolysis pathway. Therefore, we assume that lncRNA-PTCHD3P1 inhibits PFK-1 expression, and PFK-1 down-regulation inhibits the Warburg effect of pancreatic cancer, finally enhances chemosensitivity of gemcitabine and inhibits cancer cell proliferation and metastasis. In conclusion: lncRNA-PTCHD3P1 pathway regulating pancreatic cancer metabolism and provide metabolic prospective for treatment of pancreatic cancer.


doi: 10.21037/apc.2018.AB042


Cite this article as: Wang J, Li K. LncRNA-PTCHD3P1 enhances chemosensitivity of gemcitabine in pancreatic cancer and inhibits cancer cell proliferation and metastasis via inhibiting Warburg effect. Ann Pancreat Cancer 2018;1:AB042. doi: 10.21037/apc.2018.AB042

Download Citation